Patient Facts Study Results Part III: SSDQA Comparison

- National continues to exhibit anomalously low proportions of patients with prescriptions and procedures in the ED and hematology specialty visits. - Nemours and Nationwide are anomalously low across the board for ED visits and hematology visits, respectively. - Stanford, as observed in the exploratory output, has an anomalously low proportion of patients with each of the labs at hematology visits. They also are anomalous for MCV labs, all labs, and all drugs in the ED.